ImmuCell Corporation (NASDAQ:ICCC) Short Interest Update
ImmuCell Corporation (NASDAQ:ICCC - Get Free Report) saw a large decline in short interest during the month of December. As of December 31st, there was short interest totaling 7,780 shares, a decline...
MarketBeat·6d ago
More News
Niche Focus & Regulation Shape the Future of Healthcare Firms
CPIX, NAII and ICCC lean into specialization, compliance and targeted growth to thrive in the niche healthcare markets.
Zacks·7d ago
ImmuCell Corporation (NASDAQ:ICCC) Short Interest Up 147.1% in December
ImmuCell Corporation (NASDAQ:ICCC - Get Free Report) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totaling 15,418 shares...
MarketBeat·27d ago
The Christmas Party Is Still Ongoing In These Stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell
Nvidia shares were up nearly 2% in Friday’s midday trade after the company entered into a non-exclusive licensing agreement with Groq for its inference technology.
Stocktwits·27d ago
The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio
AbbVie headlines today's top stock reports as Zacks highlights pharma recovery, resilient beverages and Chevron???s evolving energy outlook.
Zacks·27d ago
Top Stock Reports for AbbVie, Coca-Cola & Chevron
ABBV, KO and CVX headline Zacks' top stock reports as analysts flag growth drivers, strategic moves and key headwinds shaping 2025 outlooks.
Zacks·29d ago
ImmuCell (NASDAQ:ICCC) Stock Price Crosses Below 200-Day Moving Average - Time to Sell?
ImmuCell tumbles despite stronger margins and a rebound in EPS, as backlog dynamics pressure quarterly sales while management highlights improving operations.
ImmuCell (NASDAQ:ICCC - Get Free Report) released its quarterly earnings results on Thursday. The biotechnology company reported ($0.02) EPS for the quarter. ImmuCell had a return on equity of 6.25...